Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 4,864 shares at $2.84 ($14K) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Scheduled sale ($14k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.84 | 298 | $846 | 6.1% |
| 2 | $2.84 | 4,566 | $13K | 93.9% |
| Total | $2.84 avg | 4,864 | $14K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |